Semaglutide and related weight-loss medications, known as GLP-1 agonists, may slow biological ageing, reduce inflammation, improve cognitive function and gut health, and reduce alcohol use in people ...

Two years ago, the Opposites Attract study found no transmissions between 343 regular gay couples of differing HIV status where the HIV-positive partner had a viral load under 200 copies/ml, the ...

There have been no definite cases of HIV infection among healthcare workers following an occupational needlestick injury in the UK since 1999.

Having an undetectable viral load means that there is not enough of the virus in body fluids to pass on HIV during sex. This is sometimes referred to as 'U=U'.

The failure of one of the largest trials yet conducted of HIV drug-based prevention methods poses questions for how to turn vaginal microbicides and oral pre-exposure prophylaxis (PrEP) into methods ...

World Health Organization (WHO) is establishing an HIV pharmacovigilance programme in order to map more accurately the incidence of side effects caused by antiretroviral drugs, and to determine ...

The British HIV Association (BHIVA) has recommended that everyone living with HIV aged 40 and over should take a statin to reduce their risk of heart disease, even if they do not have raised ...

A study from South Africa and Malawi published online ahead of print in Clinical Infectious Diseases highlights the urgent need for better management of people with TB and HIV co-infection. It shows ...

A study presented at the recent 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018) aims to quantify how many people with HIV there might be in the community who both have a ...

It’s rare in any branch of medicine that a trial of a new drug can report 100% efficacy, and a first in HIV science. But that’s what happened on Friday, when Gilead Sciences announced that no HIV ...

Unanswered questions about the safety of taking PrEP during pregnancy and breastfeeding should not be allowed to stand in the way of access to PrEP for women who need it at these ...

South Africa is expected to begin piloting injectable pre-exposure prophylaxis (PrEP) in 2023, health financing mechanism Unitaid tells aidsmap. The demonstration study will be the first of many ...